Investing
Top Analyst Upgrades and Downgrades: Alphabet/Google, Exelon, Kinross Gold, Noble, Potash, Seagate Tech, Western Digital and More
Published:
Last Updated:
Stocks were indicated higher on Monday after last week’s 1% drop in the Dow, but the market is still barely hanging positive so far for the year. Now that the market recovery has negated the selling pressure of the first six weeks of 2016, investors have to decide whether they should be buying the dips or selling into the rallies.
24/7 Wall St. reviews dozens of analyst research reports each morning of the week. Our aim is to find new investing and trading ideas for our readers. Some of these daily analyst reports cover stocks to buy, and other reports cover stocks to sell or to avoid.
These are the top analyst upgrades, downgrades and initiations seen on this Monday morning:
Alphabet Inc. (NASDAQ: GOOGL) was raised to Buy from Hold and the price target was raised to $970 from $800 (versus a $759.47 prior close) at Pivotal Research. The consensus analyst price target is $926.80, and the 52-week trading range is $529.00 to $810.35.
Exelon Corp. (NYSE: EXC) was started as Neutral with a price target of $37 (versus a $34.70 close) at Goldman Sachs. Exelon has a consensus price target of $35.68 and a 52-week range of $25.09 to $35.95.
Noble Corp. PLC (NYSE: NE) was downgraded to Hold from Buy with an $11 price target (versus a $9.56 close) at Societe Generale. It has a consensus price target of $9.58 and a 52-week range of $6.66 to $18.58.
Potash Corp. of Saskatchewan Inc. (NYSE: POT) was downgraded to Hold from Buy at HSBC. The consensus price target is $17.81, and shares trade in a 52-week range of $14.64 to $33.80.
Seagate Technology PLC (NASDAQ: STX) was started as Market Perform with a $36 price target (versus a $33.23 close) at Cowen. The consensus price target is $36.22, and the 52-week range is $26.25 to $60.09. Seagate was indicated 3% higher on Monday after Barron’s touted it as having an enticing 7.5% dividend yield.
Western Digital Corp. (NYSE: WDC) was started as Market Perform with a $46 price target (versus a $43.10 close) at Cowen. The stock has a consensus price target of $70.90 and a 52-week trading range of $38.64 to $102.07.
You can follow @Jonogg to get the daily analyst calls and market reports directly on your Twitter feed.
Other key analyst upgrades and downgrades were seen on Monday in shares of the following:
AnloGold Ashanti Ltd. (NYSE: AU) was raised to Outperform from Sector Perform at RBC Capital Markets.
Apple Hospitality REIT Inc. (NYSE: APLE) was started as Market Perform with a $20 price target (versus an $18.95 close) at FBR Capital Markets.
Armada Hoffler Properties Inc. (NYSE: AHH) was reiterated as Buy and the fair value estimate was raised to $13 from $12 at Janney.
AvalonBay Communities Inc. (NYSE: AVB) was downgraded to Neutral from Buy with a $184 price target (versus a $189.20 close) at UBS.
Bloomin’ Brands Inc. (NASDAQ: BLMN) was raised to Outperform from Neutral with a $21 price target (versus a $17.12 close) at Credit Suisse.
Cabot Corp. (NYSE: CBT) was downgraded to Sector Weight from Overweight at KeyBanc Capital Markets.
Capstead Mortgage Corp. (NYSE: CMO) was downgraded to Market from Outperform at $9.80 at Wells Fargo.
Cummins Inc. (NYSE: CMI) was downgraded to Neutral from Outperform at Macquarie.
Lithia Motors Inc. (NYSE: LAD) was started as Buy with a $105 price target (versus a $79.68 close) at Jefferies.
Qlik Technologies Inc. (NASDAQ: QLIK) was downgraded to Hold from Buy with a $30 price target (versus a $29.07 close) at Deutsche Bank. Citigroup cut Qlik to Neutral from Buy as well.
Restaurant Brands International Inc. (NYSE: QSR) was raised to Outperform from Sector Perform with a $48 price target (versus a $38.03 close) at RBC Capital Markets.
Stryker Corp. (NYSE: SYK) was started as Underweight with a $107 price target (versus a $108.54 close) at Barclays.
Tobira Therapeutics Inc. (NASDAQ: TBRA) was started with a Buy rating and was assigned as $22 price target (versus a $7.30 close) at H.C. Wainwright.
United Natural Foods Inc. (NASDAQ: UNFI) was downgraded to Underweight from Equal Weight at Morgan Stanley.
Wright Medical Group N.V. (NASDAQ: WMGI) was started as Buy with a $23 price objective (versus a $17.05 close) at Bank of America Merrill Lynch.
Xylem Inc. (NYSE: XYL) was downgraded to Neutral from Outperform at Wedbush Securities.
If you missed Friday’s top analyst upgrades and downgrades, they included Apache, Baker Hughes, Intercept Pharmaceutical, Rite Aid, Synchrony Financial, U.S. Steel and over a dozen others.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.